卖什么
AI enabling digital urine diagnostics in the home
商业模式拆解
买家：谁掌握预算？
Insurers/payers reimburse the program; providers (urology and primary care clinics) prescribe it.
触发点：什么让他们现在购买？
未核实Recurrent UTI patients and clinics wanting early intervention and fewer repeat visits and antibiotic courses.
工作流：什么输入变成什么输出？
Patient uses UrinDx at-home device each time they use the bathroom; algorithms track trends; Starling care team triages and escalates to the clinician when symptoms are confirmed.
经济账：省了什么，怎么收费？
Program is reimbursed by insurance; most patients pay $0 for UrinDx; providers get triage reimbursement. FDA clearance pending.
渠道：怎么接触到客户？
Through partnered providers and a patient eligibility check form.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2022 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.